Back to Search
Start Over
Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice
- Source :
- Molecular Neurobiology
- Publication Year :
- 2021
- Publisher :
- Springer Science and Business Media LLC, 2021.
-
Abstract
- Alzheimer’s disease (AD) is the most common cause of senile dementia and one of the greatest medical, social, and economic challenges. According to a dominant theory, amyloid-β (Aβ) peptide is a key AD pathogenic factor. Aβ-soluble species interfere with synaptic functions, aggregate gradually, form plaques, and trigger neurodegeneration. The AD-associated pathology affects numerous systems, though the substantial loss of cholinergic neurons and α7 nicotinic receptors (α7AChR) is critical for the gradual cognitive decline. Aβ binds to α7AChR under various experimental settings; nevertheless, the functional significance of this interaction is ambiguous. Whereas the capability of low Aβ concentrations to activate α7AChR is functionally beneficial, extensive brain exposure to high Aβ concentrations diminishes α7AChR activity, contributes to the cholinergic deficits that characterize AD. Aβ and snake α-neurotoxins competitively bind to α7AChR. Accordingly, we designed a chemically modified α-cobratoxin (mToxin) to inhibit the interaction between Aβ and α7AChR. Subsequently, we examined mToxin in a set of original in silico, in vitro, ex vivo experiments, and in a murine AD model. We report that mToxin reversibly inhibits α7AChR, though it attenuates Aβ-induced synaptic transmission abnormalities, and upregulates pathways supporting long-term potentiation and reducing apoptosis. Remarkably, mToxin demonstrates no toxicity in brain slices and mice. Moreover, its chronic intracerebroventricular administration improves memory in AD-model animals. Our results point to unique mToxin neuroprotective properties, which might be tailored for the treatment of AD. Our methodology bridges the gaps in understanding Aβ-α7AChR interaction and represents a promising direction for further investigations and clinical development. Supplementary Information The online version contains supplementary material available at 10.1007/s12035-020-02270-0.
- Subjects :
- 0301 basic medicine
Nicotinic acetylcholine receptor
alpha7 Nicotinic Acetylcholine Receptor
Amyloid beta
Neurotoxins
Neuroscience (miscellaneous)
Apoptosis
Mice, Transgenic
Hippocampus
Article
Mice
03 medical and health sciences
Cellular and Molecular Neuroscience
0302 clinical medicine
Alzheimer Disease
medicine
Animals
Neurotoxin
Cognitive Dysfunction
Cognitive decline
Cholinergic neuron
Amyloid beta-Peptides
biology
Chemistry
Neurodegeneration
Cholinergic hypothesis
Long-term potentiation
Models, Theoretical
medicine.disease
Cholinergic Neurons
Disease Models, Animal
030104 developmental biology
Neurology
biology.protein
Cholinergic
Snake α-neurotoxin
Amyloid-beta
Alzheimer’s disease
Neuroscience
030217 neurology & neurosurgery
Protein Binding
Subjects
Details
- ISSN :
- 15591182 and 08937648
- Volume :
- 58
- Database :
- OpenAIRE
- Journal :
- Molecular Neurobiology
- Accession number :
- edsair.doi.dedup.....f4a9c4a89dd3c5e37a6549ae5c969542
- Full Text :
- https://doi.org/10.1007/s12035-020-02270-0